Your browser doesn't support javascript.
loading
Effect of Severe Renal Dysfunction on the Plasma Levels of DNA-Reactive Platinum after Oxaliplatin Administration.
Nakagawa, Shunsaku; Shimazaki, Aimi; Funakoshi, Taro; Yonezawa, Atsushi; Kataoka, Shigeki; Horimatsu, Takahiro; Hira, Daiki; Itohara, Kotaro; Imai, Satoshi; Nakagawa, Takayuki; Matsubara, Takeshi; Yanagita, Motoko; Muto, Manabu; Matsubara, Kazuo; Terada, Tomohiro.
Afiliação
  • Nakagawa S; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital.
  • Shimazaki A; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital.
  • Funakoshi T; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University.
  • Yonezawa A; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital.
  • Kataoka S; Graduate School of Pharmaceutical Sciences, Kyoto University.
  • Horimatsu T; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University.
  • Hira D; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University.
  • Itohara K; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital.
  • Imai S; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital.
  • Nakagawa T; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital.
  • Matsubara T; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital.
  • Yanagita M; Department of Nephrology, Graduate School of Medicine, Kyoto University.
  • Muto M; Department of Nephrology, Graduate School of Medicine, Kyoto University.
  • Matsubara K; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University.
  • Terada T; Department of Pharmacy, Wakayama Medical University Hospital.
Biol Pharm Bull ; 46(2): 194-200, 2023.
Article em En | MEDLINE | ID: mdl-36724948

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxaliplatina / Nefropatias Limite: Animals Idioma: En Revista: Biol Pharm Bull Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxaliplatina / Nefropatias Limite: Animals Idioma: En Revista: Biol Pharm Bull Ano de publicação: 2023 Tipo de documento: Article